Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. A
A logo

A Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Agilent Technologies Inc (A) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
120.710
1 Day change
-0.95%
52 Week Range
160.270
Analysis Updated At
2026/04/16
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Agilent Technologies Inc is not a strong buy for a beginner, long-term investor at this moment. While the company has a stable financial performance and positive long-term analyst sentiment, the lack of immediate positive catalysts, neutral trading trends, and no strong proprietary trading signals suggest holding off on investment for now.

Technical Analysis

The MACD is positively contracting above 0, indicating a mild bullish trend. RSI is neutral at 58.96, and moving averages are converging, suggesting no clear directional trend. The stock is trading near its pivot point (117.153), with resistance at 120.556 and support at 113.749.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • Analyst sentiment remains positive overall, with multiple firms maintaining Buy or Outperform ratings. Revenue growth of 6.96% YoY in Q1 2026 indicates a stable business trajectory.

Neutral/Negative Catalysts

  • Net income and EPS have declined YoY, reflecting potential profitability challenges. Gross margin has also slightly contracted. No significant news or event-driven catalysts in the past week. Trading trends from hedge funds and insiders are neutral.

Financial Performance

In Q1 2026, revenue increased by 6.96% YoY to $1.798 billion. However, net income dropped by 4.09% YoY to $305 million, and EPS decreased by 3.60% YoY to $1.07. Gross margin contracted slightly to 52.89%, down 1.10% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets recently, with the majority now targeting $140-$145. However, most maintain positive ratings such as Buy or Overweight. Sentiment remains cautiously optimistic, with some analysts highlighting sector risks but expecting recovery in the long term.

Wall Street analysts forecast A stock price to rise
13 Analyst Rating
Wall Street analysts forecast A stock price to rise
12 Buy
1 Hold
0 Sell
Strong Buy
Current: 121.870
sliders
Low
160
Averages
171.67
High
180
Current: 121.870
sliders
Low
160
Averages
171.67
High
180
Barclays
Luke Sergott
Overweight
downgrade
$150 -> $140
AI Analysis
2026-04-14
Reason
Barclays
Luke Sergott
Price Target
$150 -> $140
AI Analysis
2026-04-14
downgrade
Overweight
Reason
Barclays analyst Luke Sergott lowered the firm's price target on Agilent to $140 from $150 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science and diagnostic tools group as part of a Q1 preview. Barclays likes the setup for the sector but says it is "not without risk." Sentiment is at all-time lows and Barclays still believes in the "last-cut thesis (for the most part)," the analyst tells investors in a research note.
Evercore ISI
Outperform
to
Outperform
downgrade
$160 -> $140
2026-04-06
Reason
Evercore ISI
Price Target
$160 -> $140
2026-04-06
downgrade
Outperform
to
Outperform
Reason
Evercore ISI lowered the firm's price target on Agilent to $140 from $160 and keeps an Outperform rating on the shares as part of the firm's medical technology and life science tools Q1 preview.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for A
Unlock Now

People Also Watch